Case Study: Affinivax advances vaccine R&D and scales faster with LabCentral

Affinivax scales its team from 4-5 employees to the largest suite at LabCentral

Affinivax, a young biotech startup with a novel vaccine technology, faced significant challenges scaling its laboratory operations and building its team within Cambridge's competitive ecosystem. The company needed a fully equipped lab and a supportive community to attract talent and build industry relationships, without being burdened by the administrative complexities of permits, procurement, and hazardous waste management. They turned to vendor LabCentral for its shared laboratory facilities and resources.

LabCentral provided Affinivax with a fully equipped, compliant lab environment and a vibrant community, allowing the startup to focus its energy on hiring scientists and advancing its vaccine platform. The flexible space model enabled Affinivax to grow at its own pace, eventually expanding to the largest available suite. The solution delivered significant results: Affinivax successfully scaled its operations, advanced its R&D, built a strong team, and was ultimately acquired by GSK.

Affinivax